Nanotech's near-term payoff is energy and medicine

by Lena Novak

Nanotech has a branding problem — people imagine grey-goo nanobots. The reality is less cinematic and more useful: nanostructured electrodes for batteries, targeted drug delivery, water filtration, better solar. I work on the battery side and we're squeezing real gains out of nanostructuring right now. The "tiny machines repairing your cells" future is real but distant. The boring nanotech is already in your phone and will be in your medicine within years.

favorite 25 comment 3 visibility 185

Comments

Hannah Schmidt 3 weeks ago

Targeted drug delivery is the one I watch most — nanocarriers could make a lot of toxic drugs viable.

Hannah Schmidt 1 hour ago

From the wet-lab side: the nano/bio boundary is dissolving. Lipid nanoparticles were "nanotech" the moment they delivered mRNA vaccines into a billion arms, and almost nobody called them that. The near-term payoff Lena describes is already here; it just got filed under biotech.

Jonas Iversen 6 minutes ago

Materials scientist here, I live in the battery corner of exactly this. Lena's "boring nanotech" framing is right and I'd push it one step further: nanostructuring matters most because everything downstream is rate-limited by joules per kilo and per dollar. A better electrode isn't a niche win — cheaper, denser storage is what quietly unlocks EVs, the grid, medical implants, even the compute buildout everyone's arguing about. On the medicine side Hannah's lipid-nanoparticle point is the tell: we already shipped nanotech into a billion arms and just didn't call it that. The hype cycle wants cell-repair nanobots; the real revolution is a 15% better anode nobody writes a headline about. Crack storage and the whole downstream stack accelerates at once.